SightGlass Vision is the lead sponsor of 9 current clinical trials in our USA and China registers. 4 are recruiting patients now. All registered phases are Not applicable. The most-studied condition is Juvenile Myopia.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
NCT06034327 · Myopia, Juvenile Myopia, Myopia Progression
|
Not applicable | Recruiting | 2023-09 | USA |
|
Assessment of DOT Spectacles in Chinese Children Extension
NCT07008001 · ClinicalTrials.gov ↗ · Juvenile Myopia, Myopia
|
Not applicable | Recruiting | 2025-08 | China |
|
Mobility Performance in Daily Activities Among Children Wearing Spectacle Lenses
NCT07229352 · ClinicalTrials.gov ↗ · Myopia, Myopia Progression, Juvenile Myopia
|
Not applicable | Recruiting | 2026-02 | USA |
|
Children's Viewing Behavior
NCT07229365 · ClinicalTrials.gov ↗ · Myopia, Myopia Progression, Juvenile Myopia
|
Not applicable | Recruiting | 2025-12 | USA |
|
Control of Myopia Using Novel Spectacle Lens Designs
NCT03623074 · Juvenile Myopia
|
Not applicable | Active, closed | 2018-07 | USA |
|
CYPRESS Efficacy and Safety Study Extension
NCT04947735 · Juvenile Myopia, Myopia
|
Not applicable | Active, closed | 2021-07 | USA |
|
Spectacle Lens Visual Acuity Assessments Study
NCT05650190 · ClinicalTrials.gov ↗ · Myopia, Myopia Progression, Juvenile Myopia
|
Not applicable | Active, closed | 2022-12 | USA |
|
Myopia Control Spectacle Lens Cessation Study
NCT05893979 · ClinicalTrials.gov ↗ · Myopia, Myopia Progression, Juvenile Myopia
|
Not applicable | Active, closed | 2023-06 | USA |
|
Assessment of DOT Spectacles in Chinese Children
NCT05562622 · ClinicalTrials.gov ↗ · Juvenile Myopia, Myopia
|
Not applicable | Active, closed | 2023-02 | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 7 | 3 |
| Clinical trials in China | 2 | 1 |
A trial with sites in more than one country appears in each of those registers.
SightGlass Vision is the lead sponsor of 9 current trials on ClinicalTrials.gov in our USA and China registers, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 4 of its 9 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.